Post-Acute COVID/Vaccination Syndrome: evidence brief
Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 · https://research.opensourcemed.info/briefs/post-acute-covidvaccination-syndrome.html
Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.
Medicines with registered trials
Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.
- Immunoadsorption 2 trials
- 6-minute walk 1 trial
- Active 1 trial
- Computed Tomography of the Chest 1 trial
- COVAXIN 1 trial
- DAOIB (see NCT05764538) 1 trial
Non-drug approaches tested
Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.
- Herbal medicines and traditional formulas 1 trials · 1 completed · 0 with results
- Exercise programmes (mixed or unspecified) 2 trials · 1 completed · 0 with results
Biomarkers reported
Direction in patients compared with the stated comparison group, as reported in the cited study.
- S1 in CD16+ monocytes higher · Patterson et al. 2025
- Circulating spike (post-mRNA myocarditis) higher · Yonker et al. 2023
- Spike in cutaneous lesions higher · Sano et al. 2025
- Spike in neurological tissue higher · Ota et al. 2025
- Anti-Spike (Anti-S) antibodies higher · Federico 2024
- Anti-Nucleocapsid (Anti-N) antibodies lower · Federico 2024
Trials recruiting
Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.
- Low Dose Sirolimus in People With Post-Acute Sequelae of COVID-19 (PASC) Long… NCT06960928